Glimepiride Powder 99.36% Pharmaceutical Raw Materials CAS 93479-97-1
Pharmaceutical Raw Materials Glimepiride Powder,99.36% Glimepiride
Fórmula molecular:C24H34N4O5S
Peso de la fórmula: 490.62
No CAS.:93479-97-1
Pureza:99.36%
Apariencia: off white powder
Glimepiride (original trade name Amaryl) is an orally available medium-to-long-acting sulfonylurea antidiabetic drug. It is sometimes classified as either the first third-generation sulfonylurea,or as second-generation.
Glimepiride is indicated to treat type 2 diabetes mellitus; its mode of action is to increase insulin production by the pancreas. It is not used for type 1 diabetes because in type 1 diabetes the pancreas is not able to produce insulin.
Its use is contraindicated in patients with hypersensitivity to glimepiride or other sulfonylureas.
The COA:
| Nombre del producto |
Glimepiride |
| CAS No. |
93479-97-1 |
Embalaje exterior |
25KG/drum |
| Fecha de producción |
2016.7.12 |
Duración |
2019.07.11 |
| Norma adoptada |
Estándar de la empresa |
| Elementos de análisis |
Especificación |
Resultados |
|
Apariencia |
White or off white powder |
off white powder |
|
Solubilidad |
Two soluble in dimethylformamide, soluble in dichloromethane two chloride, slightly soluble in methanol, prácticamente insoluble en agua |
Cumple |
| Identificación |
IR map should be consistent with the control map |
Cumple |
| Metal pesado |
≤10 ppm |
Cumple |
| Cis-isomer(A) |
≤0.8% |
0.20% |
|
Sulfonamide(B) |
≤0.4% |
0.11% |
| Urethane(C) |
≤0.1% |
DAKOTA DEL NORTE |
| 3-isómero(D) |
≤0.2% |
DAKOTA DEL NORTE |
| Cualquier otra impureza |
≤0.1% |
0.08% |
| Impurezas totales |
≤0,5% |
0.12% |
| Residuos en ignición |
≤0.2% |
0.08% |
| Pérdida por secado |
≤0,5% |
0.16% |
| Ensayo |
98.0% ～102.0 % |
99.36% |
| Conclusión |
Calificado |
Gerente de ventas